Here, we have examined the mechanisms of autophagy that have been reported in endometrial cancers, including the function of the p53 and mTOR/ERDj-4/PTEN signaling pathways, which either initiate or inhibit the process and are therefore viable molecular targets for therapeutic strategies. The gene discussed is TP53; the disease is endometrial cancer.